Frontlight ResearchEarly access
Sickle cell disease trials in French Guiana
1 of 1 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 2Taking peoplePharmacokinetics, Efficacy and Safety of Twice Daily Dosing Regimen of Hydroxycarbamide Dispersible Tablets in Children With Sickle Cell Disease
- Where
- Cayenne
- Age
- 9 months to 11 years
- People
- 50 worldwide
- Run by
- Theravia
See details and how to joinNCT06578507